Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan 1;372(1):78-89.
doi: 10.1056/NEJMsr1407164.

Atypical hyperplasia of the breast--risk assessment and management options

Lynn C Hartmann  1 , Amy C Degnim, Richard J Santen, William D Dupont, Karthik Ghosh
Affiliations

Atypical hyperplasia of the breast--risk assessment and management options

Lynn C Hartmann et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1. Microanatomical Features of the Breast and Histologic Features of Atypical Hyperplasia
Panel A shows atypical ductal hyperplasia with a proliferation of monotonous cells in architecturally complex patterns, including secondary lumens and micropapillary formations (reproduced from Hartmann et al.). Panel B shows atypical lobular hyperplasia, with expanded acini filled with monotonous polygonal cells and a loss of acinar lumens. Panel C shows multifocal atypical hyperplasia (in this case, atypical lobular hyperplasia). Atypical lobular hyperplasia is present in more than one terminal duct lobular unit, which are clearly separated from one another by interlobular mammary stroma (arrows). Panel D is an illustration of the microanatomy of the breast, including a photomicrograph of a terminal duct lobular unit.
Figure 2
Figure 2. Cumulative Incidence of Breast Cancer after a Diagnosis of Atypical Hyperplasia
Shown is the cumulative incidence of breast cancer (invasive and ductal carcinoma in situ) after a diagnosis of atypical hyperplasia in the Mayo Clinic cohort (Panel A) and in the same cohort stratified according to the number of foci of atypical hyperplasia (Panel B). The dashed lines in Panel A denote 95% confidence intervals.
See this image and copyright information in PMC

Comment in

  • Atypical hyperplasia of the breast.
    Hartmann LC, Degnim AC, Dupont WD. Hartmann LC, et al. N Engl J Med. 2015 Mar 26;372(13):1271-2. doi: 10.1056/NEJMc1501046. N Engl J Med. 2015. PMID: 25806929 No abstract available.
  • Atypical hyperplasia of the breast.
    Brentnall AR, Cuzick J. Brentnall AR, et al. N Engl J Med. 2015 Mar 26;372(13):1269-70. doi: 10.1056/NEJMc1501046. N Engl J Med. 2015. PMID: 25806930 No abstract available.
  • Atypical hyperplasia of the breast.
    Reimers LL, Crew KD, Terry MB. Reimers LL, et al. N Engl J Med. 2015 Mar 26;372(13):1270-1. doi: 10.1056/NEJMc1501046. N Engl J Med. 2015. PMID: 25806931 Free PMC article. No abstract available.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Gutwein LG, Ang DN, Liu H, et al. Utilization of minimally invasive breast biopsy for the evaluation of suspicious breast lesions. Am J Surg. 2011;202:127–32. - PubMed
    1. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312:146–51. - PubMed
    1. Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005;353:229–37. - PubMed
    1. Simpson JF. Update on atypical epithelial hyperplasia and ductal carcinoma in situ. Pathology. 2009;41:36–9. - PubMed
    1. Hartmann LC, Radisky DC, Frost MH, et al. Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study. Cancer Prev Res (Phila) 2014;7:211–7. - PMC - PubMed

Publication types

Substances